International Journal of Biological Sciences
ISSN: 1449-2288
10
Impact Factor
ISSN: 1449-2288
Global reach, higher impact
Int J Biol Sci 2025; 21(9):4129-4130. doi:10.7150/ijbs.113876 This issue Cite
Erratum
cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum
YeLing Ruan1,2*, TianYi Chen1,2*, LongBo Zheng5*, JingWei Cai1,2, Hu Zhao1,2, YaLi Wang1,2, LiYe Tao1,2, JunJie Xu1,2,3,4 
, Lin Ji1,2, , XiuJun Cai1,2,3,4#
1. Key Laboratory of Laparoscopic Technology of Zhejiang Province, Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine - Hangzhou, China.
2. Zhejiang Minimal Invasive Diagnosis and Treatment Technology Research Center of Severe Hepatobiliary Disease, Zhejiang Research and Development Engineering Laboratory of Minimally Invasive Technology and Equipment - Hangzhou, China.
3. Zhejiang University Cancer Center - Hangzhou, China.
4. Liangzhu Laboratory, Zhejiang University Medical Center - Hangzhou, China.
5. Department of Gastroenterology, The Affiliated Hospital of Qingdao University - Qingdao, China
*These authors contributed equally to this work and share first authorship.
#Lead contact.
Published 2025-6-16
Citation:
Ruan Y, Chen T, Zheng L, Cai J, Zhao H, Wang Y, Tao L, Xu J, Ji L, Cai X. cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum. Int J Biol Sci 2025; 21(9):4129-4130. doi:10.7150/ijbs.113876. https://www.ijbs.com/v21p4129.htm
Other stylesCorrected-article in Int J Biol Sci, Volume 19, 4608
In our paper, the author noticed the following non subjective errors. We have rechecked the raw data to ensure that the conclusions of the article are not affected by errors. In this regard, all authors agree with the errata, and we apologize for any inconvenience caused by work negligence.
HCCLM3-SR data in Figure 1F should be corrected as follows.
Figure 1
(F) Correct image.
The fourth sentence of the third paragraph in background should be corrected as follows.
Nikolaus Rajewsky and colleagues proposed the functional miRNA sponge model. They identified 63 miR-7 binding sites in CDR1as, a circRNA that inhibits the actions of miR-7 [36].
References: 36. Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013;495:333-8.
Tumor metastasis data in Table 1 should be corrected as follows.
Table 1
Tumor metastasis data
| Variable | TOP2A expression | P value | |
|---|---|---|---|
| Low(n=38) N(%) | High(n=46) N(%) | ||
| Tumor metastasis | 0.0187* | ||
| No | 36(94.7%) | 35(76.1%) | |
| Yes | 2(5.3%) | 11(23.9%) | |
Author contact
Corresponding authors: Xiujun Cai - srrsh_cxjedu.cn, Lin Ji - jilinedu.cn, Junjie Xu - walter235edu.cn.
Citation styles
APA
Ruan, Y., Chen, T., Zheng, L., Cai, J., Zhao, H., Wang, Y., Tao, L., Xu, J., Ji, L., Cai, X. (2025). cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum. International Journal of Biological Sciences, 21(9), 4129-4130. https://doi.org/10.7150/ijbs.113876.
ACS
Ruan, Y.; Chen, T.; Zheng, L.; Cai, J.; Zhao, H.; Wang, Y.; Tao, L.; Xu, J.; Ji, L.; Cai, X. cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum. Int. J. Biol. Sci. 2025, 21 (9), 4129-4130. DOI: 10.7150/ijbs.113876.
NLM
Ruan Y, Chen T, Zheng L, Cai J, Zhao H, Wang Y, Tao L, Xu J, Ji L, Cai X. cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum. Int J Biol Sci 2025; 21(9):4129-4130. doi:10.7150/ijbs.113876. https://www.ijbs.com/v21p4129.htm
CSE
Ruan Y, Chen T, Zheng L, Cai J, Zhao H, Wang Y, Tao L, Xu J, Ji L, Cai X. 2025. cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum. Int J Biol Sci. 21(9):4129-4130.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.